Abstract
In this study, tranexamic acid (TA) was used as a model compound to study the charge effect on the physicochemical properties of poly(lactic-co-glycolic acid) (PLGA) microparticles (MPs). Charged PLGA MPs were elaborated by the incorporation of a quaternary ammonium, cetyltrimethylammonium bromide (CTAB), during the double emulsion solvent evaporation process. Three TA-CTAB-carrying modes of PLGA MPs were designed in the CTAB-free (TA-MP), adsorption (TA-CTABAD), or encapsulation (TA-CTABEN) form. The obtained MPs were characterized by morphology and TA-MP affinity. The experiment revealed that the three prepared MPs were spherical and smooth, with pores on their surfaces. TA-CTABAD had a relatively narrow size distribution, compared with that of TA-MP and TA-CTABEN. The particle sizes of TA-MP, TA-CTABEN, TA-CTABAD were measured as 59 ± 17, 54 ± 20, and 19 ± 8 μm, respectively. The zeta potential of the three MPs was found to be in the order: TA-CTABAD > TA-CTABEN > TA-MP. Differential scanning calorimetry (DSC) indicated that the manufacturing process had no influence on the glass transition temperature of the MPs, which was close to 48 °C. Thermogravimetric analysis illustrated that the presence of CTAB slightly changed the thermal stability of PLGA MPs. In vitro release showed that TA-CTABAD exhibited faster TA release than TA-MP and TA-CTABEN in a basic environment (pH of 13), probably because of electrostatic attraction. At pH = 1, the release of TA from TA-CTABEN was faster than those from TA-MP and TA-CTABAD, probably because of electrostatic repulsion. However, the effect of electrostatic interaction was not significant at pH = 7.4.
Highlights
Poly(lactic-co-glycolic acid) (PLGA) microparticles (MPs) have been widely used as a carrier for the controlled release of candidate drugs [1,2]
The surface charge of PLGA MPs has been utilized for certain applications, such as decreasing plasma protein adsorption [3], carrying genes [4], and targeting cells [5]
It is interesting to investigate the effect of the interior charge of PLGA MPs on their drug release ability
Summary
Poly(lactic-co-glycolic acid) (PLGA) microparticles (MPs) have been widely used as a carrier for the controlled release of candidate drugs [1,2]. The surface charge of PLGA MPs has been utilized for certain applications, such as decreasing plasma protein adsorption [3], carrying genes [4], and targeting cells [5]. It plays a role in various delivery systems in the context of their function on drug delivery, as has been described in the literature [6,7,8,9]. The relationship between the elaborating process sequence and drug release ability of charged PLGA MPs remains unclear. It is interesting to investigate the effect of the interior charge of PLGA MPs on their drug release ability.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.